The Moving Average Convergence Divergence (MACD) for ANIK turned positive on October 13, 2026. Looking at past instances where ANIK's MACD turned positive, the stock continued to rise in 37 of 52 cases over the following month. The odds of a continued upward trend are 71%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ANIK's RSI Oscillator exited the oversold zone, 15 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 47%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on ANIK as a result. In 77 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
ANIK moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIK advanced for three days, in 167 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
ANIK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for ANIK crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
The Aroon Indicator for ANIK entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.056) is normal, around the industry mean (10.407). P/E Ratio (-78.111) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (2.177) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (2.401) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ANIK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
FLGT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 01, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 41 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 85%.
The 10-day RSI Indicator for FLGT moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 20 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FLGT as a result. In 56 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
FLGT moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for FLGT moved above the 200-day moving average on October 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where FLGT advanced for three days, in 188 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
FLGT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 112 of 161 cases where FLGT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.549) is normal, around the industry mean (66.046). P/E Ratio (-7.064) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.013) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. FLGT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FLGT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
ANIK | FLGT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 73 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | 36 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 93 | |
PRICE GROWTH RATING 1..100 | 36 | 55 | |
P/E GROWTH RATING 1..100 | 100 | 43 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ANIK's Valuation (10) in the Pharmaceuticals Other industry is in the same range as FLGT (36) in the Medical Or Nursing Services industry. This means that ANIK’s stock grew similarly to FLGT’s over the last 12 months.
ANIK's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as FLGT (100) in the Medical Or Nursing Services industry. This means that ANIK’s stock grew similarly to FLGT’s over the last 12 months.
ANIK's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as FLGT (93) in the Medical Or Nursing Services industry. This means that ANIK’s stock grew similarly to FLGT’s over the last 12 months.
ANIK's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as FLGT (55) in the Medical Or Nursing Services industry. This means that ANIK’s stock grew similarly to FLGT’s over the last 12 months.
FLGT's P/E Growth Rating (43) in the Medical Or Nursing Services industry is somewhat better than the same rating for ANIK (100) in the Pharmaceuticals Other industry. This means that FLGT’s stock grew somewhat faster than ANIK’s over the last 12 months.
| ANIK | FLGT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 47% | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 70% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 68% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 80% |
| Advances ODDS (%) | 1 day ago 63% | 3 days ago 69% |
| Declines ODDS (%) | 21 days ago 68% | 1 day ago 76% |
| BollingerBands ODDS (%) | 1 day ago 63% | 1 day ago 74% |
| Aroon ODDS (%) | 1 day ago 73% | 1 day ago 70% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANIK’s FA Score shows that 1 FA rating(s) are green while FLGT’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANIK’s TA Score shows that 5 TA indicator(s) are bullish while FLGT’s TA Score has 5 bullish TA indicator(s).
ANIK (@Pharmaceuticals: Generic) experienced а +1.73% price change this week, while FLGT (@Medical Specialties) price change was -4.19% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.
ANIK is expected to report earnings on Nov 04, 2026.
FLGT is expected to report earnings on Nov 05, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Medical Specialties (-3.15% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with RVTY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then RVTY could also see price increases.
| Ticker / NAME | Correlation To ANIK | 1D Price Change % | ||
|---|---|---|---|---|
| ANIK | 100% | +2.38% | ||
| RVTY - ANIK | 39% Loosely correlated | +0.48% | ||
| ORGO - ANIK | 36% Loosely correlated | +3.90% | ||
| ACRS - ANIK | 34% Loosely correlated | +0.52% | ||
| FLGT - ANIK | 32% Poorly correlated | -0.70% | ||
| INFU - ANIK | 32% Poorly correlated | +0.64% | ||
More | ||||
A.I.dvisor indicates that over the last year, FLGT has been loosely correlated with MYGN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGT jumps, then MYGN could also see price increases.
| Ticker / NAME | Correlation To FLGT | 1D Price Change % | ||
|---|---|---|---|---|
| FLGT | 100% | -0.70% | ||
| MYGN - FLGT | 41% Loosely correlated | +3.41% | ||
| CERS - FLGT | 40% Loosely correlated | -3.35% | ||
| BIO - FLGT | 39% Loosely correlated | +0.83% | ||
| NVST - FLGT | 38% Loosely correlated | +3.36% | ||
| MXCT - FLGT | 38% Loosely correlated | -2.72% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FXU | 47.83 | 1.01 | +2.16% |
| First Trust Utilities AlphaDEX Fund (FXU) | |||
| BSMV | 20.22 | 0.05 | +0.23% |
| Invesco BulletShares 2031 Municipal Bond ETF (BSMV) | |||
| XBOC | 36.49 | -0.26 | -0.70% |
| Innovator U.S. Equity Accelerated 9 Buffer ETF - October (XBOC) | |||
| CGUS | 44.37 | -0.67 | -1.49% |
| Capital Group Core Equity ETF (CGUS) | |||
| TEKX | 48.70 | -3.41 | -6.54% |
| State Street Galaxy Transformative Tech Accelerators ETF (TEKX) | |||